2007
DOI: 10.1016/j.brainres.2007.07.056
|View full text |Cite
|
Sign up to set email alerts
|

Melatonin ameliorates blood–brain barrier permeability, glutathione, and nitric oxide levels in the choroid plexus of the infantile rats with kaolin-induced hydrocephalus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
19
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 31 publications
(20 citation statements)
references
References 31 publications
1
19
0
Order By: Relevance
“…Future work is required to examine this hypothesis as well as to evaluate the function and stability of the choroid plexus and arachnoid membrane in post-mortem and imaging studies in schizophrenia. Results from studies in the fields of stroke, brain injury and liver failure, have shown that such compounds as melatonin, idazoxan, an imidazoline 2 receptor ligand, and inhibitors of matrix metalloproteinases may protect against blood-brain barrier and choroid plexus pathologies induced by a variety of methods in cell culture experiments and rodent models (Chen et al, 2013; Turgut et al, 2007; Verma et al, 2010; Wang et al, 2014). Thus, based on this work, therapies aimed to remove the antigenic source and to normalize endothelial barrier functions may be applicable treatment modalities to explore for safety and efficacy trials in schizophrenia.…”
Section: Discussionmentioning
confidence: 99%
“…Future work is required to examine this hypothesis as well as to evaluate the function and stability of the choroid plexus and arachnoid membrane in post-mortem and imaging studies in schizophrenia. Results from studies in the fields of stroke, brain injury and liver failure, have shown that such compounds as melatonin, idazoxan, an imidazoline 2 receptor ligand, and inhibitors of matrix metalloproteinases may protect against blood-brain barrier and choroid plexus pathologies induced by a variety of methods in cell culture experiments and rodent models (Chen et al, 2013; Turgut et al, 2007; Verma et al, 2010; Wang et al, 2014). Thus, based on this work, therapies aimed to remove the antigenic source and to normalize endothelial barrier functions may be applicable treatment modalities to explore for safety and efficacy trials in schizophrenia.…”
Section: Discussionmentioning
confidence: 99%
“…The absence of such a change in hydrocephalic rats further supports the idea that generalized BBB dysfunction is not a major phenomenon. One group claimed that detection of Tc99-diethylenetriamine penta-acetate DTPA in brain using a gamma camera following intravenous injection of the tracer into hydrocephalic rats was evidence of BBB breakdown [50]; however, only a single animal was used in each group and therefore the data cannot be considered credible. Increased levels of S-100 protein (20 kDa) in blood plasma of children with hydrocephalus were claimed to be indicative of BBB disruption [51]; however, this just as likely represents absorption of released S-100 through conventional CSF absorption routes.…”
Section: Discussionmentioning
confidence: 99%
“…It is worth mentioning, however, that BBB permeability is not constant, but depends on the physiological state of animals. It was previously found that BBB permeability could be affected by the level of gonadal steroids (Wilson et al, 2008), melatonin (Turgut et al, 2007), and stress (Esposito et al, 2001). So it can be speculated that the varied results on the ability of LPS to cross the BBB could be, at least partially, caused by the different physiological states of the animals used in those studies.…”
Section: Discussionmentioning
confidence: 99%